M
MRNA
MRNA7 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$6.3B7.3%
FY2024
Operating Segments
7Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Product Sales
Segment Shift
Product Sales has grown from 26.5% to 49.0% of total revenue since FY2020, with 0.0% operating margins. Meanwhile, COVID19 is the fastest growing at 0.0% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Product Sales | $3.1B | $0 | 0.0% | 49.0% | -53.4% |
| COVID19 | $3.1B | $0 | 0.0% | 48.6% | +0.0% |
| Collaboration Arrangement Including Arrangements With Affiliate | $48M | $0 | 0.0% | 0.8% | -42.2% |
| License And Royalty | $42M | $0 | 0.0% | 0.7% | +0.0% |
| Grant | $37M | $0 | 0.0% | 0.6% | -60.6% |
| RSV | $25M | $0 | 0.0% | 0.4% | +0.0% |
| License And Service | $0 | $0 | 0.0% | 0.0% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free